Visual acuity (VA) of eyes initially treated with antivascular endothelial growth factor (anti-VEGF) therapy has improved from baseline to 5 years without protocol-defined treatment after follow-up ended at 2 years, a study has found. Additionally, mean retinal thickness is comparable at 2 and 5 years, but mean VA has worsened during this period.
Patients with acute anterior uveitis (AAU) see elevated levels of serum amyloid A (SAA), which may help in monitoring inflammatory processes and assess the efficacy of therapies, a recent study has found.
A novel botanical combination of lutein ester, zeaxanthin, and extracts of blackcurrant, chrysanthemum, and goji berry provides protective benefits in adults with eye fatigue without changing the retinal structure, a study has shown.
Intravitreal conbercept in three monthly loading doses, followed by a pro re nata regimen, is safe and effective for patients with macular oedema secondary to central retinal vein occlusion (CRVO), a recent China study has shown.
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa,
08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.